|
Aug 27
|
3 Ways the Democratic Party's Platform Could Impact Biotech and Pharma Stocks if Implemented
|
|
Aug 27
|
Pfizer launches DTC service for migraine, COVID drugs
|
|
Aug 27
|
Pfizer, joining Lilly, enters the direct-to-consumer market with a telehealth and prescription platform
|
|
Aug 27
|
Pfizer Launches PfizerForAll™, a Digital Platform that Helps Simplify Access to Healthcare
|
|
Aug 24
|
Want $2,000 in Annual Dividends? Invest $30,000 in These 3 High-Yielding Stocks
|
|
Aug 23
|
The FDA Approved New Covid Vaccines. Should You Get One?
|
|
Aug 23
|
FDA Approves Pfizer & Moderna's Updated COVID-19 Jabs
|
|
Jan 16
|
Pfizer’s Bourla Bets His Pension on Company Stock as CEO Defends Drug Firm
|
|
Jan 15
|
I'm Passing on Pfizer Stock in 2024. Here's Why.
|
|
Jan 14
|
Is Pfizer Stock a Buy in 2024?
|
|
Jan 13
|
7 Incredible Reasons to Buy Pfizer Stock Right Now
|
|
Jan 13
|
2 Red Flags That Could Sink Pfizer in 2024
|
|
Jan 12
|
As diversity, equity and inclusion comes under legal attack, companies quietly alter their programs
|
|
Jan 12
|
Pharma Stock Roundup: MRK to Buy Harpoon, JNJ to Acquire Ambrx Biopharma & More
|
|
Jan 11
|
UPDATE 1-Weight loss drug windfall attracts pharma companies
|
|
Jan 11
|
Drugmakers plot way into obesity market with deals and development
|
|
Jan 11
|
A Bull Market Is Coming: 2 Magnificent Stocks Down More Than 50% to Buy Right Now
|
|
Jan 10
|
Pfizer Recommends Shareholders Reject the Below-Market Mini-Tender Offer by TRC Capital Investment Corporation
|
|
Jan 10
|
JPM's annual healthcare conference: Here's what's next for GLP-1s and the weight loss market
|
|
Jan 10
|
UPDATE 1-US FDA allows import of syphilis drug to address shortages
|